Pfizer Becomes 1st Vaccine To Be Approved For Children Aged 12-15

Pfizer-BioNTech's COVID-19 vaccine has become the first vaccine globally to be approved for children aged between 12-15 years. The vaccine was approved by the European Union drug regulator on May 28 with no "major concerns" remark. Following the approval, Germany plans to start vaccinating those aged 12 and above in June. Notably, the trials of the vaccine were conducted on 1,005 children and none of them developed any major side-effect.